All Type of News
KRW 53.2 billion spent for migraine in a year
Since the number of patients suffering from migraine caused by insomniac, fatigue and stress increases every year, the yearly medical expenses for migraine reached KRW 53.2 billion.
According to the analysis result o...
Pharmaceutical Korea Wave in Middle East, starting in Iran
The domestic pharmaceutical industry which participated in the President Guen-hye Park’s state visit to Iran as the economic delegation has accelerated the target to the Middle Eastern market, such as a series of expo...
“Are Gaviscon and Strepsils Oxy products?”
Although Oxy Reckitt Benckiser(current RB Korea) held the press conference for apology in 5 years after the humidifier germicide incident, the boycott does not seem to be calmed down against Oxy’s products.
Started ...
Which will take 2nd po2sition in anticoagulant market?
It’s getting more interesting and interesting. Competition is getting fiercer over the 2nd position for anticoagulants after warfarin.
According to the IMS’s data, the total prescriptions of new oral anticoagulants(N...
‘Stivarga Tab’ settled by RSA, becoming the 10th
The risk sharing agreement(RSA) for Stivarga Tab, a Bayer’s regorafenib gastrointestinal tumor treatment was settled. Thus, it became the 10th RSA-applied drug, starting with Evoltra Inj on December 2013.
The Nationa...
No. 1 birth control pill, Mercilon, hugged by Alvogen Korea
‘Mercilon Tab,’ a birth control pill that was sold the most in Korea, is now taken over by Alvogen Korea.
According to a confirmation on the 3rd, a company approved for Mercilon Tab was exchanged from Bayer Korea to...
‘Apology for criticism avoidance’ triggers boycott against Oxy
Although Oxy Reckitt Benckiser has announced the formal position for victims of the humidifier germicide incident, the boycott against its products will be more widely spread under the criticism that it was only an ‘a...
Activation of Korea-Iran healthcare expansion, followed by 5 pharmaceutical MOUs
While the Korea-Iran summit meeting was held, healthcare results such as 5 MOUs have been made in the pharmaceutical field.
On the 2nd, the Ministry of Health and Welfare announced results – healthcare cooperation, i...
Weakened profitability is ‘labor pain to become global pharmaceuticals’
Some of the top pharmaceutical companies have been weakened in profitability due to active expansion of investments in R&D.
According to the pharmaceutical industry, triggered by the Hanmi Pharm’s successful cases, t...
Dong-A ST’s Stillen & Zydena decreased, Motilitone increased on 1st quarterOn the 2nd, Dong-A ST announced it recorded KRW 146.9 billion sales increased by 5.3%, KRW 11.7 billion profits decreased by 8.5% and KRW 4.5 billion net profits decreased by 48...
|
